Prevention of endometrial hyperplasia without atypia in women of reproductive age

Objective of this review is a systematic analysis of the data available in the current literature on the efficacy and safety of progestogens for the prevention of atypical endometrial hyperplasia (EH) in patients of reproductive age. EH is an excessive proliferation that results in increased volume...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mekan R. Orazov, Ljudmila M. Mihaleva, Roman E. Orekhov, Irina A. Mullina
Formato:	article
Lenguaje:	RU
Publicado:	IP Berlin A.V. 2021
Materias:	endometrial hyperplasia progestogens dlyjens pro Gynecology and obstetrics RG1-991
Acceso en línea:	https://doaj.org/article/e7dd5ac9a07d4f768a5806ea31624fa3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e7dd5ac9a07d4f768a5806ea31624fa3
record_format	dspace
spelling	oai:doaj.org-article:e7dd5ac9a07d4f768a5806ea31624fa32021-12-02T19:22:24ZPrevention of endometrial hyperplasia without atypia in women of reproductive age2079-56962079-583110.26442/20795696.2021.5.201217https://doaj.org/article/e7dd5ac9a07d4f768a5806ea31624fa32021-11-01T00:00:00Zhttps://gynecology.orscience.ru/2079-5831/article/viewFile/83491/pdfhttps://doaj.org/toc/2079-5696https://doaj.org/toc/2079-5831Objective of this review is a systematic analysis of the data available in the current literature on the efficacy and safety of progestogens for the prevention of atypical endometrial hyperplasia (EH) in patients of reproductive age. EH is an excessive proliferation that results in increased volume and changes in endometrial tissue architectonics with an increase in the endometrial glands to stroma ratio of more than 1:1. This review will consider the use of progestogens for the prevention of (EH) based on evidence-based scientific evidence over the past 5 years. The expansion of the range of effective treatment options allows the adaptation of treatment to the needs of patients and offers a personalized approach to their management. Progestogens are an effective and safe method for the prevention of atypical hyperplasia, with a wide range of therapeutic benefits associated with reliable favorable fertility prognosis, especially in young women.Mekan R. OrazovLjudmila M. MihalevaRoman E. OrekhovIrina A. MullinaIP Berlin A.V. articleendometrial hyperplasiaprogestogensdlyjens proGynecology and obstetricsRG1-991RUГинекология, Vol 23, Iss 5, Pp 454-458 (2021)
institution	DOAJ
collection	DOAJ
language	RU
topic	endometrial hyperplasia progestogens dlyjens pro Gynecology and obstetrics RG1-991
spellingShingle	endometrial hyperplasia progestogens dlyjens pro Gynecology and obstetrics RG1-991 Mekan R. Orazov Ljudmila M. Mihaleva Roman E. Orekhov Irina A. Mullina Prevention of endometrial hyperplasia without atypia in women of reproductive age
description	Objective of this review is a systematic analysis of the data available in the current literature on the efficacy and safety of progestogens for the prevention of atypical endometrial hyperplasia (EH) in patients of reproductive age. EH is an excessive proliferation that results in increased volume and changes in endometrial tissue architectonics with an increase in the endometrial glands to stroma ratio of more than 1:1. This review will consider the use of progestogens for the prevention of (EH) based on evidence-based scientific evidence over the past 5 years. The expansion of the range of effective treatment options allows the adaptation of treatment to the needs of patients and offers a personalized approach to their management. Progestogens are an effective and safe method for the prevention of atypical hyperplasia, with a wide range of therapeutic benefits associated with reliable favorable fertility prognosis, especially in young women.
format	article
author	Mekan R. Orazov Ljudmila M. Mihaleva Roman E. Orekhov Irina A. Mullina
author_facet	Mekan R. Orazov Ljudmila M. Mihaleva Roman E. Orekhov Irina A. Mullina
author_sort	Mekan R. Orazov
title	Prevention of endometrial hyperplasia without atypia in women of reproductive age
title_short	Prevention of endometrial hyperplasia without atypia in women of reproductive age
title_full	Prevention of endometrial hyperplasia without atypia in women of reproductive age
title_fullStr	Prevention of endometrial hyperplasia without atypia in women of reproductive age
title_full_unstemmed	Prevention of endometrial hyperplasia without atypia in women of reproductive age
title_sort	prevention of endometrial hyperplasia without atypia in women of reproductive age
publisher	IP Berlin A.V.
publishDate	2021
url	https://doaj.org/article/e7dd5ac9a07d4f768a5806ea31624fa3
work_keys_str_mv	AT mekanrorazov preventionofendometrialhyperplasiawithoutatypiainwomenofreproductiveage AT ljudmilammihaleva preventionofendometrialhyperplasiawithoutatypiainwomenofreproductiveage AT romaneorekhov preventionofendometrialhyperplasiawithoutatypiainwomenofreproductiveage AT irinaamullina preventionofendometrialhyperplasiawithoutatypiainwomenofreproductiveage
_version_	1718376770809364480

Prevention of endometrial hyperplasia without atypia in women of reproductive age

Ejemplares similares